However, it is frustrating that long-term use of TMZ in GBM patients inevitably leads to the overexpression of O6-methylguanine DNA methyltransferase (MGMT) in GBM cells, which results in the resistance of GBM cells to TMZ. Here, MGMT is linked to glioblastoma.